ATC code L
ATC code L Antineoplastic and immunomodulating agents is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QL.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
L Antineoplastic and immunomodulating agents |
---|
L01 Antineoplastic agents |
L02 Endocrine therapy |
L03 Immunostimulants |
L04 Immunosuppressants |
A
B
C
D
G
H
QI
J
L
M
N
P
R
S
V
|
References[edit | edit source]
- ↑ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 2020-02-01.
- ↑ "ATC-Klassifikation mit definierten Tagesdosen DDD" (in Deutsch). German Institute for Medical Documentation and Information. Retrieved 2020-02-01.
- ↑ "ATC/DDD Index 2022: code L". WHO Collaborating Centre for Drug Statistics Methodology.
- ↑ "ATCvet Index 2022: code QL". WHO Collaborating Centre for Drug Statistics Methodology.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD